ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization
Crossref DOI link: https://doi.org/10.1007/s00428-016-2005-y
Published Online: 2016-08-25
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, Andrew S
Greer, Wenda
Bethune, Drew
Craddock, Kenneth J
Flowerdew, Gordon
Xu, Zhaolin
Funding for this research was provided by:
Pfizer (WS1416261)
License valid from 2016-08-25